Key result
Non-improved VExUS score in acute heart failure is linked to ~77% higher post-discharge events.
Why the study?
The determinants of VExUS score trajectory during hospitalization and the prognostic implications of persistent subclinical congestion at discharge in acute heart failure remain poorly defined.
Does a non-improved VExUS score during hospitalization predict all-cause mortality or heart failure hospitalization in patients with acute heart failure?
Cohort (n=418)
Does a non-improved VExUS score during hospitalization predict all-cause mortality or heart failure hospitalization in patients with acute heart failure?
Hazard Ratio: 1.77 (95% CI 1.17–2.67)
p-value: p=0.007
Persistent venous congestion assessed by a non-improving VExUS score during hospitalization for acute heart failure is independently associated with worse long-term outcomes and provides incremental prognostic value over standard parameters.
Persistent severe congestion (VExUS 3) at discharge signals higher mid-term risk in acute HF; supports trials testing targeted decongestion before practice change.
Background: Reliable quantification of systemic venous congestion in acute heart failure (HF) has become feasible with the advent of the venous excess ultrasound (VExUS) score, informing therapeutic management. Nevertheless, the determinants of the VExUS score trajectory during hospitalization and the prognostic implications of persistent subclinical congestion at discharge remain poorly defined. Methods: Consecutive patients admitted for acute HF were prospectively enrolled (n = 418, 73.3 ± 11.8 years old, 59.1% male). VExUS scores were assessed at admission and prior to discharge to categorize the patients into three groups: non-congested (persistent score of 0; n = 81), improved (score reduction of ≥1 point; n = 214), and non-improved (persistent congestion without score reduction; n = 123). Baseline clinical data were collected and all the patients had a transthoracic echocardiogram on admission. All patients were followed up post-discharge and the primary endpoint was a composite of all-cause mortality or HF hospitalization. Results: Patients with non-improved VExUS exhibited a higher burden of right-sided remodeling and dysfunction including larger right chambers, lower right ventricle (RV) systolic function indices, higher RV systolic pressures and a higher prevalence of severe tricuspid regurgitation (all p < 0.001). Severe tricuspid regurgitation was the sole independent predictor of VExUS non-improvement (OR 2.86, 95% CI 1.51–5.45, p = 0.001). Non-improved VExUS (HR 1.77; 95% CI 1.17–2.67; p = 0.007), severe tricuspid regurgitation (HR 1.88; 95% CI 1.16–3.02; p = 0.010) and intravenous furosemide dose (HR 1.00; 95% CI 1.00–1.01; p = 0.011) were independent predictors of the composite primary endpoint. Inclusion of non-improved VExUS provided incremental prognostic value over models including clinical, laboratory, and echocardiographic parameters (Δχ2= 9.22; p = 0.007). Conclusions: VExUS non-improvement throughout hospitalization marks patients with worse primary endpoint Severe tricuspid regurgitation emerges as an independent determinant of VExUS non-improvement which is independently associated with poor long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Peteinidou et al. (2026) conducted a cohort in Acute heart failure (n=418). Non-improved VExUS score (persistent congestion) vs. Improved or non-congested VExUS score was evaluated on Composite of all-cause mortality or heart failure hospitalization (HR 1.77, 95% CI 1.17-2.67, p=0.007). Non-improved VExUS score during hospitalization for acute heart failure was associated with an increased risk of mortality or HF hospitalization (HR 1.77; 95% CI 1.17-2.67; p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: